Galina Goloverda PhD

Galina Goloverda PhD

Professor

A Theranostic Agent Construction:     Development of New Strategies for Peptide Conjugation.

We are developing novel magnetic theranostic agents based on ultra-small superparamagnetic nanoparticulate maghemite covered with covalently attached non-polymeric amphiphilic organic shell.  Organic shell termini are being conjugated with a peptide for cancerous cells’ recognition.

Selected Publications:

(a) Tenacic Acids: a New Class of Tenacious Binders to Metal Oxide Surfaces. Rajesh Komati, Carl Mitchell, Anastasia LaBeaud, Huy Do, Galina Goloverda and Vladimir Kolesnichen-ko, Chemistry-A European Journal, 2018, 24, 14824-14829.

(b) A Versatile Method of Ambient-Temperature Solvent Remov-al. Igor Kolesnichenko, Galina Goloverda and Vladimir Kole-snichenko, Organic Process Research & Development, 2020, 24, 25-31.

Topics & Keywords: Organic Linkers, Superparamagnetic nanoparticles, Cell labels, MRI Contrast Agents

ORCID: https://orcid.org/0000-0002-4903-8005

NCBI: http://www.ncbi.nlm.nih.gov/sites/myncbi/1xM95ZtRbOyQ/bibliography/48732709/public/?

LCRC Faculty

Samuel J. Landry PhD
Translational Oncology
Tulane University School of Medicine
Elisa Ledet, PhD
Translational Oncology
Tulane University School of Medicine
Sean Bong Lee PhD
Cancer Biology
Tulane University School of Medicine
KiTani Lemieux PhD
Population Sciences
Xavier University
Brian Lewis, Phd
Translational Oncology
Tulane University School of Medicine
Li LI MD PhD
Cancer Biology
Ochsner Health
Zhen Lin MD PhD
Genes X Environment
Tulane University School of Medicine
Hui-Yi Lin PhD
Population Sciences
LSU Health - New Orleans
Yong-Yu Liu PhD
Translational Oncology
University of Louisiana Monroe